Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 30335131

Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixto.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Ann Oncol
Publication date
2018 Dec 1
First author
Loibl S

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Ann Oncol. 2018 Dec 1;29(12):2278-2280. doi: 10.1093/annonc/mdy494.
    note
    Source null
    related pmid
    30395152
    relationship
    Comment in

Authors and identifiers

  1. name
    Loibl S
    type
    Author
  2. name
    Weber KE
    type
    Author
  3. name
    Timms KM
    type
    Author
  4. name
    Elkin EP
    type
    Author
  5. name
    Hahnen E
    type
    Author
  6. name
    Fasching PA
    type
    Author
  7. name
    Lederer B
    type
    Author
  8. name
    Denkert C
    type
    Author
  9. name
    Schneeweiss A
    type
    Author
  10. name
    Braun S
    type
    Author
  11. name
    Salat CT
    type
    Author
  12. name
    Rezai M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Loibl S
    type
    Author
  2. name
    Weber KE
    type
    Author
  3. name
    Timms KM
    type
    Author
  4. name
    Elkin EP
    type
    Author
  5. name
    Hahnen E
    type
    Author
  6. name
    Fasching PA
    type
    Author
  7. name
    Lederer B
    type
    Author
  8. name
    Denkert C
    type
    Author
  9. name
    Schneeweiss A
    type
    Author
  10. name
    Braun S
    type
    Author
  11. name
    Salat CT
    type
    Author
  12. name
    Rezai M
    type
    Author
bibliography ids
  1. nci-bib-ece344f8f648e52155cd5c33
book metadata
content sha256
888f94171bc74be326745cce35b3238c3c9be8b43b4c1b141193b857e0f05b56
document type
citation
dois
  1. 10.1093/annonc/mdy460
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:30335131
immutable id
pubmed:30335131@888f94171bc74be326745cce35b3238c3c9be8b43b4c1b141193b857e0f05b56
journal
abbreviation
Ann Oncol
issn electronic
1569-8041
issn print
0923-7534
issue
12
name
Annals of oncology : official journal of the European Society for Medical Oncology
nlm unique id
9007735
pages
2341-2347
volume
29
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    Ann Oncol. 2018 Dec 1;29(12):2278-2280. doi: 10.1093/annonc/mdy494.
    note
    Source null
    related pmid
    30395152
    relationship
    Comment in
outcomes validated
false
pmid
30335131
provenance
batch id
438b2803888025c6cf56
provider
NCBI PubMed ESummary
record sha256
c6e60e1ae97236d6f5196bc6e3c10348ab33797b375069fce64286abdeaf01e2
response sha256
0adf5ff07d3aa03a45feef5e4b7998e2ddea370eb9d1c6aa9134c5fd329767e6
retrieved at
2026-09-09T23:47:36.359220+00:00
publication date
display
2018 Dec 1
precision
day
year
2018
publication types
  1. Clinical Trial, Phase II
  2. Clinical Trial, Phase III
  3. Journal Article
  4. Randomized Controlled Trial
  5. Research Support, Non-U.S. Gov't
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/30335131/
title
Survival analysis of carboplatin added to an anthracycline/taxane-based neoadjuvant chemotherapy and HRD score as predictor of response-final results from GeparSixto.

Preserved source evidence · Not medical advice